Nab-paclitaxel and S-1 in Patients With Locally Advanced Pancreatic Cancer

NCT03885219 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Pancreatic Cancer

Interventions

DRUG: Nab-paclitaxel and S-1

Sponsor

Peking Union Medical College Hospital